Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Profile of entrectinib and its potential in the treatment of ROS1-positive NSCLC: evidence to date
InChiKey: ZEBBPGHOLWPSGI-UHFFFAOYSA-N
Like other nitroimidazoles
is inactive against MTH1 in vitro
VU6001376 is a potent and selective positive allosteric modulator of the metabotropic glutamate receptor 4 (mGlu4 PAM) with an EC50 of 50
Beta-Lipotropin (1-10), porcine oumaric Acid Profile of entrectinib and itsMorphine like substances exist in brain or the pituitary of various species. Beta lipotropin (beta LPH) was found to contain within its C terminal sequence the primary structure of these peptides. Identity between the sequence of isolated fragments and thecarboxy terminal portion of the corresponding beta lipotropins hasalso been observed in human and in porcine pituitary and hypothalamic neurohypophysis extracts. Product information CAS Number: 77875
US$ 53.00
US$ 24.60
US$ 52.00
US$ 55.00
US$ 111.40
US$ 52.00
US$ 53.00
US$ 48.00
US$ 78.00